Labetalol Hydrochloride Injection
Product Images NDC 83301-0059
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Labetalol Hydrochloride (NDC 83301-0059). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Mullan Pharmaceutical Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Principal Display Panel (20 mL Vial Carton)
This is a label for Labetalol Hydrochloride Injection, which contains 100 mg/20 mL (5 mg/mL) of the medication. It provides details about the manufacturer, dosage, composition, storage instructions, and administration route. The label also includes a unique Pharma Code: 865 for identification purposes. It is important for medical professionals to refer to the package insert for adult dosage and administration recommendations. The medication is for intravenous injection only and is supplied in a 20 mL Multiple-Dose Vial.*
Principal Display Panel (40 mL Vial Carton)
The text contains information about Labetalol Hydrochloride injection, USP in a 40mL multiple-dose vial with a concentration of 200 mg/40 mL (5 mg/mL). It specifies that the injection is for intravenous use only and lists the composition of each mL. The storage instructions, manufacturer details, and a Pharma Code are also provided. The text ends with the mention of the revision date.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.